Metabolomic Analyses Reveal Extensive Progenitor Cell Deficiencies in a Mouse Model of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a musculoskeletal disorder that causes severe morbidity and reduced lifespan. Individuals with DMD have an X-linked mutation that impairs their ability to produce functional dystrophin protein in muscle. No cure exists for this disease and the few therapies that...
Main Authors: | Josiane Joseph, Dong Seong Cho, Jason D. Doles |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-1989/8/4/61 |
Similar Items
-
Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01) -
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy
by: Sarah E. Henson, et al.
Published: (2021-10-01) -
A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01) -
Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01)